The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development

Scott Stroup, T.; P. McEvoy, Joseph; S Swartz, M; Byerly, Matthew; D. Glick, Ira; M. Cañive, José; F. McGee, Michael; M. Simpson, G.; C. Stevens, Michael; A. Lieberman, Jeffrey

doi:10.1093/oxfordjournals.schbul.a006986

Public

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development

Published in Schizophrenia Bulletin • Jan 1, 2003

Authors:

T. Scott Stroup

Joseph P. McEvoy

M S Swartz

Abstract

The National Institute of Mental Health initiated the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) program to evaluate the effectiveness of antipsychotic drugs in typical settings and populations so that the study results will be maximally useful in routine clinical situations...

Subject

Ziprasidone

Quetiapine

Olanzapine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!